Barchart Impact
Tue, Feb 10th, 2026
Most Recent Stories
/Technicians%20Supervise%20Energy%20Plant.jpg)
Policy shifts under the Trump administration are fueling a domestic energy resurgence, creating a $2.1T opportunity for Frontieras North America. With patented technology that converts coal i
/Masterworks%20Artwork.png)
Markets may look strong, but the article argues five risks are piling up: extreme S&P 500 concentration, gains reliant on sustained AI spending, stocks and bonds moving together, a roughly 10
/Masterworks_GeoRisk.png)
In 2026, geopolitical and policy risks are driving higher risk premiums and pushing investors toward alternative diversifiers like art.
GT Biopharma announced it has submitted an IND to the FDA for GTB-5550, its third NK cell engager entering clinical development for B7-H3–expressing solid tumors, while reporting a strengthen
Critical Metals and USA Rare Earth are advancing large-scale projects to establish alternative rare earth supply chains outside of China, offering active traders high-conviction opportunities to amplify...
/Semiconductor%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
The AI semiconductor supply chain, driven by manufacturing leaders like Lam Research, connectivity innovators such as Astera Labs and Credo, and power specialist Navitas, presents high-conviction opportunities...
/FundingTicks.jpg)
FundingTicks has set a new industry benchmark for corporate accountability by winding down its operations with integrity, ensuring transparency, and prioritizing the fair distribution of $30 million in...
/Paladin%20Power%20battery.png)
AI’s explosive growth is driving massive electricity demand, straining an aging U.S. power grid and pushing costs onto households through higher rates and outages. As utilities struggle to ke
%20destroying%20a%20cancer%20cell%20by%20Alpha%20Tauri%203D%20Graphics%20via%20Shutterstock.jpg)
GT Biopharma (GTBP) received FDA clearance to begin human trials of its TriKE®-based cancer therapy GTB-5550, marking a strategic expansion from blood cancers into the much larger solid tumor market by...
/Virtuix%20VTW%20system%20on%20the%20battlefield.jpg)
Virtuix Inc., fresh off its Nasdaq debut as VTIX, is integrating AI-driven Gaussian splatting into its Virtual Terrain Walk system to rapidly turn real-world locations into photorealistic, ph
